Bioheart, Inc. , a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announces an update on the phase I safety trial using adipose derived cells.
http://ift.tt/1uqR9Xq
http://ift.tt/1uqR9Xq
No comments:
Post a Comment